Canonical: https://ownershiptrace.com/13f/companies/3353

# Who owns ANI PHARMACEUTICALS INC (ANIP)? Elite investor 13F holders

4 tracked elite investors reported holding ANI PHARMACEUTICALS INC as of 2026-06-30, including Rubric Capital, D.E. Shaw, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Rubric Capital](https://ownershiptrace.com/13f/investors/120) | ANI PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 21368084.00 USD | 258131.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1687509/0001104659-26-097098-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | ANI PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14464315.00 USD | 174732.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | ANI PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 5273086.00 USD | 63700.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | ANI PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 498915.00 USD | 6027.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | ANI PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)